Literature DB >> 27737913

Clostridium difficile infection in dialysis patients.

Ankita Tirath1, Sandra Tadros1, Samuel L Coffin1, Kristina W Kintziger2, Jennifer L Waller2, Stephanie L Baer1,3, Rhonda E Colombo1, Lu Y Huber1,3, Mufaddal F Kheda1,4, N Stanley Nahman1,3.   

Abstract

Clostridium difficile infection (CDI) is the most common cause of nosocomial diarrhea. Patients with end-stage renal disease (ESRD) may be at increased risk for CDI. Patients with ESRD with CDI have increased mortality, longer length of stay, and higher costs. The present studies extend these observations and address associated comorbidities, incidence of recurrence, and risk factors for mortality. We queried the United States Renal Data System (USRDS) for patients with ESRD diagnosed with CDI, and assessed for the incidence of infection, comorbidities, and mortality. The records of 419,875 incident dialysis patients from 2005 to 2008 were reviewed. 4.25% had a diagnosis of a first CDI. In the majority of patients with CDI positive, a hospitalization or ICU stay was documented within 90 days prior to the diagnosis of CDI. The greatest adjusted relative risk (aRR) of CDI was present in patients with HIV (aRR 2.68), age ≥65 years (aRR 1.76), and bacteremia (aRR 1.74). The adjusted HR (aHR) for death was 1.80 in patients with CDI. The comorbidities demonstrating the greatest risk for death in dialysis patients with CDI included age ≥65 years and cirrhosis (aHR 2.28 and 1.76, respectively). Recurrent CDI occurred in 23.6%, was more common in Caucasians, and in those who were older. CDI is a common occurrence in patients with ESRD, with elderly patients, patients with HIV positive, and bacteremic patients at highest risk for infection. Patients with CDI had nearly a twofold increased risk of death.
Copyright © 2016 American Federation for Medical Research.

Entities:  

Keywords:  Clostridium difficile; Comorbidity; Kidney Failure, Chronic; Risk

Mesh:

Year:  2016        PMID: 27737913     DOI: 10.1136/jim-2016-000183

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  3 in total

1.  Clinical Determinants Predicting Clostridioides difficile Infection among Patients with Chronic Kidney Disease.

Authors:  Łukasz Lis; Andrzej Konieczny; Michał Sroka; Anna Ciszewska; Kornelia Krakowska; Tomasz Gołębiowski; Zbigniew Hruby
Journal:  Antibiotics (Basel)       Date:  2022-06-08

2.  Metronidazole therapy as initial treatment of Clostridium difficile infection in patients with chronic kidney disease in Korea.

Authors:  Jaeuk Shin; Yu Mi Wi; Yu-Ji Lee
Journal:  Epidemiol Infect       Date:  2019-10-14       Impact factor: 2.451

3.  Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.

Authors:  Kairav J Shah; Kartikeya Cherabuddi; Kalynn B Pressly; Kaitlyn L Wright; Ashutosh Shukla
Journal:  BMC Nephrol       Date:  2020-03-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.